Ginkgo Bioworks was founded with the mission to make biology easier to engineer. We have built the world\'s first organism engineering foundry in our 18,000 sqft facility in Boston and have an outstanding team using the foundry to bring new organisms to customers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/31/15 | $9,000,000 | Series A |
Data Collective Felicis Ventures iGlobe Partners OS Fund Vast Ventures | undisclosed |
| 07/23/15 | $45,000,000 | Series B |
Felicis Ventures OS Fund Viking Global Investors Y Combinator | undisclosed |
| 06/08/16 | $100,000,000 | Series C |
Allen & Company Baillie Gifford Cascade Investment Senator Investment Group Viking Global Investors Y Combinator | undisclosed |
| 12/14/17 | $275,000,000 | Series D |
Cascade Investment General Atlantic Viking Global Investors Y Combinator | undisclosed |
| 12/15/17 | $275,000,000 | Series D |
Cascade Investment General Atlantic Viking Global Investors Y Combinator | undisclosed |
| 09/19/19 | $290,000,000 | Series E |
Cascade Investment Data Collective Felicis Ventures General Atlantic iGlobe Partners OS Fund Senator Investment Group T. Rowe Price Associates Vast Ventures Viking Global Investors Y Combinator | undisclosed |
| 05/30/20 | $70,000,000 |
General Atlantic Illumina, Inc Viking Global Investors | undisclosed |
